Valeant Pharma (VRX) CEO Papa: Dermatology has Been 'A Challenge' for Us - Bloomberg

September 13, 2016 9:24 AM EDT

Get the Pulse of the Market with's Pulse Picks. Get your Free Trial here.

Valeant Pharma (NYSE: VRX) CEO Joe Papa commented today that dermatology has been "a challenge" for us, according o Bloomberg.

Papa also commented:

  • We're seeing growth in new prescriptions for Salix
  • We plan to spend more in R&D in branded prescriptions
  • We've stopped DTC advertising in 2016
  • We plan to announce sales of assets by end of 2016

Papa is speaking at the Morgan Stanley Global Healthcare Conference this morning at 10:00am ET. The webcast is here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Management Comments, Trader Talk

Related Entities

Morgan Stanley

Add Your Comment